Inactive Instrument

News Mirati Therapeutics

Equities

MRTX

US60468T1051

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

British billionaire Joe Lewis intends to plead guilty to US charges, lawyer says	Jan. 24	RE
Mirati Therapeutics, Inc.(NasdaqGS:MRTX) dropped from S&P Biotechnology Select Industry Index	Jan. 24	CI
Mirati Therapeutics, Inc.(NasdaqGS:MRTX) dropped from S&P TMI Index	Jan. 24	CI
Mirati Therapeutics, Inc.(NasdaqGS:MRTX) dropped from S&P Global BMI Index	Jan. 24	CI
Bristol-Myers Squibb Closes Acquisition of Mirati Therapeutics	Jan. 23	MT
Bristol-Myers Squibb Closes Mirati Therapeutics Acquisition	Jan. 23	MT
Bristol Myers: acquisition of Mirati Therapeutics finalized	Jan. 23	CF
Mirati Therapeutics, Inc. Announces Management Changes	Jan. 23	CI
Mirati Therapeutics, Inc.(NasdaqGM:MRTX) dropped from NASDAQ Composite Index	Jan. 23	CI
Bristol-Myers Squibb Company completed the acquisition of Mirati Therapeutics, Inc. from a group of shareholders.	Jan. 22	CI
Mirati Therapeutics, Inc.(NasdaqGS:MRTX) dropped from NASDAQ Biotechnology Index	Jan. 22	CI
Mirati Therapeutics - European Commission Approves KRAZATI as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer with a KRASG12C Mutation	Jan. 11	AQ
Mirati Therapeutics' Krazati Lung Cancer Treatment Gets EU Conditional Marketing Authorization	Jan. 10	MT
European Commission Approves KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation	Jan. 10	PR
Bristol Myers expects to launch 16 new products through 2030 - CEO	Jan. 08	RE
Immunome Appoints Phil Roberts as Chief Technical Officer	Jan. 04	MT
US FDA turns down Amgen lung cancer drug Lumakras for full approval	Dec. 26	RE
Bristol-Myers Agrees Deal to Buy RayzeBio for About $4.1 Billion	Dec. 26	MT
Bristol-Myers Squibb Strikes $14 Billion Deal to Acquire Karuna Therapeutics	Dec. 22	MT
North American Morning Briefing : Stock Futures -2-	Dec. 21	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Mirati Therapeutics

Equities

MRTX

US60468T1051

Summary

Filters